Nahdi Medical Co. announces its Annual Financial results for the period ending on 2023-12-31

Nahdi Medical Co. announces its Annual Financial results for the period ending on 2023-12-31

Total Share Holders Equity (After Deducting the Minority Equity)

2,462.8

2,243.4

9.78

Profit (Loss) per Share

6.87

6.83

All figures are in (Millions) Saudi Arabia, Riyals

Element List

Amount

Percentage of the capital (%)

Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value

All figures are in (Millions) Saudi Arabia, Riyals

Element List

Explanation

The reason of the increase (decrease) in the sales/ revenues during the current year compared to the last year

Revenue: In 2023, Nahdi posted revenue of SAR 8,713.7 million, an increase of 1.1% or SAR 97.5 million, as compared to SAR 8,616.2 million in FY 2022. The increase was due to growth in the Pharma segment as well as healthcare and UAE business. This growth was partially offset by a decline in certain divisions within the Front Shop segment.

It is worth noting that the company's overall revenue grew by 3.6% in Q4 2023 compared to the same period last year. The uptick in revenue was driven mainly by investments in promotions (please refer to the attached press release for detailed analysis).

The reason of the increase (decrease) in the net profit during the current year compared to the last year is

Net Profit: The company’s net profit was SAR 892.6 million, an increase of 0.5% or SAR 4.8 million, as compared to